chr11-55554499-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001920.3(OR4C15):c.31G>A(p.Val11Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,613,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001920.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4C15 | NM_001001920.3 | c.31G>A | p.Val11Ile | missense_variant | 1/1 | ENST00000642128.1 | NP_001001920.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4C15 | ENST00000642128.1 | c.31G>A | p.Val11Ile | missense_variant | 1/1 | NM_001001920.3 | ENSP00000493126.1 | |||
OR4C15 | ENST00000314644.2 | c.193G>A | p.Val65Ile | missense_variant | 1/1 | 6 | ENSP00000324958.2 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250824Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135516
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461680Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727138
GnomAD4 genome AF: 0.000296 AC: 45AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.193G>A (p.V65I) alteration is located in exon 1 (coding exon 1) of the OR4C15 gene. This alteration results from a G to A substitution at nucleotide position 193, causing the valine (V) at amino acid position 65 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at